99 algorithm-development-"Multiple"-"Simons-Foundation" "Prof" Postdoctoral positions at Stanford University
Sort by
Refine Your Search
-
. Requirements are a Ph.D. in immunology, publications and a willingness to learn and make use of some of the new methods we have developed, with a particular focus on human immunology and diseases. Required
-
particularly interested in leveraging the current technologies emerging in the stem cell field to develop more efficient and effective stem cell-based therapies for spinal cord injury, stroke, vascular dementia
-
analyses to determine how innate immune signaling dysregulates organization of the extracellular matrix in the developing lung. There will be opportunities to collaborate with a variety of scientists and
-
: $73,800 and $75,443 The Black Academic Development Lab at Stanford University, Anne H. Charity Hudley, Ph.D., PI, seeks to hire a postdoctoral fellow in the language, literacy, and culture of African
-
the function of such metabolites, with implications for developing new therapeutics. We welcome applicants with a background in microbiology, immunology, chemical biology, pharmacology, or cell biology to
-
publication, train and mentor graduate students on molecular techniques, and assist with proposal writing. The successful candidate will be encouraged to submit the output of their work to scientific
-
following hematopoietic stem cell transplantation. Our group works on developing targeted tools which abrogate impairments in mitochondrial dynamics as therapeutic candidates for the treatment
-
high-impact journals, as well as assist in grant writing. What We Offer: A stimulating research environment at the forefront of transplant immunology. Opportunities for professional development and
-
viral infectivity assays. The postdoc will be expected to carry out experimental laboratory and field research, write and submit manuscripts in a timely fashion for peer-reviewed publication, train and
-
to define the immune pathways that mediate the development of anti-factor antibodies in order to develop therapeutic strategies that evade or reverse the humoral immune response and promotes factor